PPP2A B Subunit Isoform B56-Epsilon: A Promising Drug Target and Biomarker

Target Name: PPP2R5E

NCBI ID: G5529

PPP2R5E

PPP2A B Subunit Isoform B56-Epsilon: A Promising Drug Target and Biomarker

PPPA (phosphatidylinositol phosphate) is a well-known protein that plays a crucial role in cellular signaling, particularly in the regulation of cell adhesion, migration, and invasion. It is a key target for many diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. The PPP2A protein is a key regulator of PPA signaling, and the B subunit isoform, B56-epsilon, has been shown to have unique functions in cell signaling and may be a promising drug target or biomarker.

The PPP2A B56-epsilon Subunit: Structure and Function

The PPP2A protein is a 21 kDa protein that consists of two subunits, A and B. The A subunit has an N-terminus that is involved in the regulation of PPA signaling, while the B subunit has a C-terminus that is involved in the regulation of PPI (phosphatidylinositol) signaling. The B subunit has a unique feature, known as B56-epsilon, which is a N-terminal extension of the B subunit that is responsible for the regulation of PPA signaling.

B56-epsilon is a 120 amino acid residue protein that is located at the N-terminus of the B subunit. It consists of a single alpha-helic acid and a single beta-sheet. The B56-epsilon protein has been shown to have unique functions in cell signaling, including the regulation of cell adhesion, migration, and invasion.

Expression and Localization

The B56-epsilon protein is expressed in many tissues and cells, including the brain, spinal cord, and peripheral tissues. It is primarily localized to the endoplasmic reticulum (ER) and is involved in the regulation of PPA signaling.

PPPA and PPI Signaling

PPPA is a well-known protein that plays a crucial role in cellular signaling. It is a key regulator of PPA signaling, which is involved in the regulation of cell adhesion, migration, and invasion. The PPA signaling pathway involves the interaction of PPA with its ligand, PIP3 (phosphatidylinositol 3-kinase), leading to the formation of PIP2 (phosphatidylinositol 2-kinase) and PIP3. The B subunit of PPP2A is involved in the regulation of PPA signaling by interacting with PIP3 and PIP2.

The B56-epsilon protein is involved in the regulation of PPI signaling, which is similar to its function in PPA signaling. It has been shown to interact with PIP3 and PIP2 and to play a role in the regulation of cellular signaling.

Drug Targeting

The B56-epsilon protein is a potential drug target due to its unique functions in cell signaling. Several studies have shown that inhibition of the B56-epsilon protein has anti-tumor effects, including a reduction in the growth of cancer cells (5) and a decrease in the migration of cancer cells.

In addition, the B56-epsilon protein has been shown to be involved in the regulation of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease. In these conditions, the B56-epsilon protein is involved in the regulation of the formation of neurotransmitter-carrying vesicles in the brain.

Biomarker

The B56-epsilon protein may also be used as a biomarker for some diseases. The B56-epsilon protein has been shown to be involved in the regulation of insulin sensitivity, which is a risk factor for many diseases, including type 2 diabetes.

Conclusion

In conclusion, the B56-epsilon protein is a unique protein that is involved in the regulation of PPA and PPI signaling. It has been shown to have unique functions in cell signaling, including the regulation of cell adhesion, migration, and invasion. The B56-epsilon protein is a potential drug target and may also be used as a biomarker for some diseases. Further research is needed to fully understand the functions of the B56-epsilon protein and its potential as a drug.

Protein Name: Protein Phosphatase 2 Regulatory Subunit B'epsilon

Functions: The B regulatory subunit might modulate substrate selectivity and catalytic activity, and also might direct the localization of the catalytic enzyme to a particular subcellular compartment

The "PPP2R5E Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PPP2R5E comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets